Geoffrey S Gottlieb
Overview
Explore the profile of Geoffrey S Gottlieb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
1690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Casto A, Paredes M, Bennett J, Luiten K, Han P, Gamboa L, et al.
Clin Chem
. 2025 Jan;
71(1):192-202.
PMID: 39749508
Background: Institutions of higher education (IHE) have been a focus of SARS-CoV-2 transmission studies but there is limited information on how viral diversity and transmission at IHE changed as the...
2.
Bennett J, OHanlon J, Acker Z, Han P, McDonald D, Wright T, et al.
BMJ Open
. 2024 Jun;
14(6):e081837.
PMID: 38834321
Objective: We aimed to evaluate the feasibility and utility of an unsupervised testing mechanism, in which participants pick up a swab kit, self-test (unsupervised) and return the kit to an...
3.
Bennett J, Luiten K, OHanlon J, Han P, McDonald D, Wright T, et al.
Vaccine
. 2024 Feb;
42(6):1332-1341.
PMID: 38307746
Vaccine effectiveness (VE) studies utilizing the test-negative design are typically conducted in clinical settings, rather than community populations, leading to bias in VE estimates against mild disease and limited information...
4.
Smith R, Raugi D, Nixon R, Seydi M, Margot N, Callebaut C, et al.
J Infect Dis
. 2023 Dec;
229(5):1290-1294.
PMID: 38060982
The activity of lenacapavir against human immunodeficiency virus type 1 (HIV-1) has been extensively evaluated in vitro, but comparable data for human immunodeficiency virus type 2 (HIV-2) are scarce. We...
5.
6.
Drain P, Dalmat R, Hao L, Bemer M, Budiawan E, Morton J, et al.
J Clin Virol
. 2023 Mar;
161:105420.
PMID: 36913789
Background: Guidelines for SARS-CoV-2 have relied on limited data on duration of viral infectiousness and correlation with COVID-19 symptoms and diagnostic testing. Methods: We enrolled ambulatory adults with acute SARS-CoV-2...
7.
Smith R, Raugi D, Nixon R, Song J, Seydi M, Gottlieb G
PLoS One
. 2023 Jan;
18(1):e0280568.
PMID: 36652466
GSK2838232 (GSK232) is a novel maturation inhibitor that blocks the proteolytic cleavage of HIV-1 Gag at the junction of capsid and spacer peptide 1 (CA/SP1), rendering newly-formed virions non-infectious. To...
8.
Li Z, Winer R, Ba S, Sy M, Lin J, Feng Q, et al.
J Infect Dis
. 2022 Oct;
227(9):1088-1096.
PMID: 36314598
Background: Persistent infection with high-risk human papillomavirus (HPV) is associated with development of invasive cervical cancer. Methods: Longitudinal data was collected from 174 Senegalese women. We employed marginal Cox proportional...
9.
Goodreau S, Stansfield S, Mittler J, Murphy J, Abernethy N, Gottlieb G, et al.
Epidemics
. 2022 Sep;
41:100629.
PMID: 36162386
Background: Set-point viral load (SPVL) correlates with the age at which people acquire HIV. Although immunosenescence may seem like a parsimonious explanation for this, it does not easily explain the...
10.
Weil A, Luiten K, Casto A, Bennett J, OHanlon J, Han P, et al.
Nat Commun
. 2022 Sep;
13(1):5240.
PMID: 36068236
Novel variants continue to emerge in the SARS-CoV-2 pandemic. University testing programs may provide timely epidemiologic and genomic surveillance data to inform public health responses. We conducted testing from September...